Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of FDA Orange Book Patents covering Doxycycline Hyclate

Client Email

Product

Doxycycline Hyclate
Methacycline
Oxytetracycline Dihydrate
US Patents

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Doxycycline Hyclate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

32 API Suppliers, 17 USDMF, 9 CEP/COS, 1 JDMF, 2 EU WC, 2 KDMF, 16 NDC API, 1 VMF, 17 Listed Suppliers, $ API Reference Price

32 API Suppliers
17 USDMF
9 CEP/COS
1 JDMF
2 EU WC
2 KDMF
16 NDC API
1 VMF
17 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

25 Drugs in Development

25 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

FINISHED DOSAGE FORMULATIONS

219 FDF Dossiers, 181 FDA Orange Book, 2 Europe, 15 Canada, 21 Listed Dossiers

219 FDF Dossiers
181 FDA Orange Book
2 Europe
15 Canada
21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 150MG BASE, TABLET;ORAL - EQ 75MG BASE, TABLET;ORAL - EQ 100MG BASE, CAPSULE;ORAL - EQ 100MG BASE, CAPSULE;ORAL - EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, DELAYED RELEASE;ORAL - EQ 100MG BASE, CAPSULE, DELAYED RELEASE;ORAL - EQ 75MG BASE, SYSTEM, EXTENDED RELEASE;PERIODONTAL - 50MG, TABLET, DELAYED RELEASE;ORAL - EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - EQ 120MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - EQ 150MG BASE, TABLET, DELAYED RELEASE;ORAL - EQ 200MG BASE, TABLET, DELAYED RELEASE;ORAL - EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - EQ 60MG BASE, TABLET, DELAYED RELEASE;ORAL - EQ 75MG BASE, TABLET, DELAYED RELEASE;ORAL - EQ 80MG BASE

TABLET;ORAL - EQ 150MG BASE
TABLET;ORAL - EQ 75MG BASE
TABLET;ORAL - EQ 100MG BASE
CAPSULE;ORAL - EQ 100MG BASE
CAPSULE;ORAL - EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, DELAYED RELEASE;ORAL - EQ 100MG BASE
CAPSULE, DELAYED RELEASE;ORAL - EQ 75MG BASE
SYSTEM, EXTENDED RELEASE;PERIODONTAL - 50MG
TABLET, DELAYED RELEASE;ORAL - EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, DELAYED RELEASE;ORAL - EQ 120MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, DELAYED RELEASE;ORAL - EQ 150MG BASE
TABLET, DELAYED RELEASE;ORAL - EQ 200MG BASE
TABLET, DELAYED RELEASE;ORAL - EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, DELAYED RELEASE;ORAL - EQ 60MG BASE
TABLET, DELAYED RELEASE;ORAL - EQ 75MG BASE
TABLET, DELAYED RELEASE;ORAL - EQ 80MG BASE

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 17 SPI Pharma, 2 Seqens, 9 DKSH, 2 Jai Radhe Sales, 8 Boai NKY Pharmaceuticals Ltd, 14 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 12 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 33 BASF, 1 Clariant, 11 Corel Pharma Chem, 7 DFE Pharma, 3 Finar, 12 Gangwal Chemicals, 8 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 40 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 22 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 29 Roquette, 14 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 4 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

104 Fillers, Diluents & Binders, 65 Coating Systems & Additives, 49 Direct Compression, 43 Disintegrants & Superdisintegrants, 39 Thickeners and Stabilizers, 36 Controlled & Modified Release, 33 Granulation, 30 Solubilizers, 29 Parenteral, 28 Film Formers & Plasticizers, 24 Taste Masking, 22 Lubricants & Glidants, 21 Co-Processed Excipients, 19 Topical, 18 Chewable & Orodispersible Aids, 9 Empty Capsules, 8 Emulsifying Agents, 8 Rheology Modifiers, 8 API Stability Enhancers, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

104 Fillers, Diluents & Binders
65 Coating Systems & Additives
49 Direct Compression
43 Disintegrants & Superdisintegrants
39 Thickeners and Stabilizers
36 Controlled & Modified Release
33 Granulation
30 Solubilizers
29 Parenteral
28 Film Formers & Plasticizers
24 Taste Masking
22 Lubricants & Glidants
21 Co-Processed Excipients
19 Topical
18 Chewable & Orodispersible Aids
9 Empty Capsules
8 Emulsifying Agents
8 Rheology Modifiers
8 API Stability Enhancers
5 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 49 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
49 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 18 Finished Drug Prices

1 US Medicaid Prescriptions
18 Finished Drug Prices

MARKET PLACE

61 APIs, 1 FDF Dossiers

61 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

14 US Patents

14 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 1 Others

2 EDQM
1 USP
1 Others

$ API Ref.Price (USD/KG) : 81 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

14 All

01 14MAYNE PHARMA

filter Patent Number Reset all filters

14 All

01 88715724

02 29295652

03 29446057

04 29511031

filter API Patent Reset all filters

14 All

01 14Blank

filter FDF Patent Reset all filters

14 All

01 14Y

filter Expiration Date Reset all filters

14 All

01 82028-02-03

02 42034-10-23

03 22034-12-23

Product Main Page

01

MAYNE PHARMA

DOXYCYCLINE HYCLATE

Formnext Forum

Not Confirmed

MAYNE PHARMA

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-10-23

DOXYCYCLINE HYCLATE

US Patent Number : 9295652

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50795

Patent Use Code : U-918

Delist Requested :

Patent Use Description : TO TREAT OR PREVENT IN...

Patent Expiration Date : 2034-10-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

MAYNE PHARMA

DOXYCYCLINE HYCLATE

Formnext Forum

Not Confirmed

MAYNE PHARMA

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-10-23

DOXYCYCLINE HYCLATE

US Patent Number : 9295652

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50795

Patent Use Code : U-918

Delist Requested :

Patent Use Description : TO TREAT OR PREVENT IN...

Patent Expiration Date : 2034-10-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

MAYNE PHARMA

DOXYCYCLINE HYCLATE

Formnext Forum

Not Confirmed

MAYNE PHARMA

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-02-03

DOXYCYCLINE HYCLATE

US Patent Number : 8715724

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50795

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-02-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

MAYNE PHARMA

DOXYCYCLINE HYCLATE

Formnext Forum

Not Confirmed

MAYNE PHARMA

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-02-03

DOXYCYCLINE HYCLATE

US Patent Number : 8715724

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50795

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-02-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

MAYNE PHARMA

DOXYCYCLINE HYCLATE

Formnext Forum

Not Confirmed

MAYNE PHARMA

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-02-03

DOXYCYCLINE HYCLATE

US Patent Number : 8715724

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50795

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-02-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

MAYNE PHARMA

DOXYCYCLINE HYCLATE

Formnext Forum

Not Confirmed

MAYNE PHARMA

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-02-03

DOXYCYCLINE HYCLATE

US Patent Number : 8715724

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50795

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-02-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

MAYNE PHARMA

DOXYCYCLINE HYCLATE

Formnext Forum

Not Confirmed

MAYNE PHARMA

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-02-03

DOXYCYCLINE HYCLATE

US Patent Number : 8715724

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50795

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-02-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

MAYNE PHARMA

DOXYCYCLINE HYCLATE

Formnext Forum

Not Confirmed

MAYNE PHARMA

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-10-23

DOXYCYCLINE HYCLATE

US Patent Number : 9511031

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50795

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-10-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

MAYNE PHARMA

DOXYCYCLINE HYCLATE

Formnext Forum

Not Confirmed

MAYNE PHARMA

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-02-03

DOXYCYCLINE HYCLATE

US Patent Number : 8715724

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50795

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-02-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

MAYNE PHARMA

DOXYCYCLINE HYCLATE

Formnext Forum

Not Confirmed

MAYNE PHARMA

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-02-03

DOXYCYCLINE HYCLATE

US Patent Number : 8715724

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50795

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-02-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?